Literature DB >> 370528

Pharmacology of ergot alkaloids in clinical use.

B Berde.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 370528     DOI: 10.5694/j.1326-5377.1978.tb77379.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  4 in total

1.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

2.  Identification and validation of uterine stimulant methylergometrine as a potential inhibitor of caspase-1 activation.

Authors:  Guillermo García-Laínez; Mónica Sancho; Vanessa García-Bayarri; Mar Orzáez
Journal:  Apoptosis       Date:  2017-10       Impact factor: 4.677

Review 3.  Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems.

Authors:  Iara Baldim; Wanderley P Oliveira; Varsha Kadian; Rekha Rao; Nitesh Yadav; Sheefali Mahant; Massimo Lucarini; Alessandra Durazzo; Raquel Da Ana; Raffaele Capasso; Selma B Souto; Antonello Santini; Eliana B Souto
Journal:  Biomolecules       Date:  2020-06-30

4.  Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes.

Authors:  Anick Bérard; Shannon Strom; Jin-Ping Zhao; Shashi Kori; Detlef Albrecht
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.